0001549084-23-000018.txt : 20230427 0001549084-23-000018.hdr.sgml : 20230427 20230427160853 ACCESSION NUMBER: 0001549084-23-000018 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230427 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230427 DATE AS OF CHANGE: 20230427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EKSO BIONICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001549084 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37854 FILM NUMBER: 23856879 BUSINESS ADDRESS: STREET 1: 101 GLACIER POINT STREET 2: SUITE A CITY: SAN RAFAEL STATE: CA ZIP: 94901 BUSINESS PHONE: 510-984-1761 MAIL ADDRESS: STREET 1: 101 GLACIER POINT STREET 2: SUITE A CITY: SAN RAFAEL STATE: CA ZIP: 94901 FORMER COMPANY: FORMER CONFORMED NAME: PN Med Group Inc DATE OF NAME CHANGE: 20120503 8-K 1 ekso-20230427.htm 8-K ekso-20230427
0001549084false00015490842023-04-272023-04-27

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

April 27, 2023
Date of Report (date of earliest event reported)

Ekso Bionics Holdings, Inc.
(Exact name of registrant as specified in its charter)
Nevada
001-3785499-0367049
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
101 Glacier Point, Suite A
San Rafael
California
94901
(Address of Principal Executive Offices)
(Zip Code)
(510) 984-1761
Registrant's telephone number, including area code

Not Applicable
________________________
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value per shareEKSO
Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o



Item 2.02 Results of Operations and Financial Condition

On April 27, 2023 Ekso Bionics Holdings, Inc. (the “Company”) reported its financial results for the three months ended March 31, 2023. The full text of the press release announcing such results is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information contained in Item 2.02 of this Current Report on Form 8-K, including the information contained in Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, and such information shall not be incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits

(d)    Exhibits
 






SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

EKSO BIONICS HOLDINGS, INC.
By:    /s/ Jerome Wong        
Name:    Jerome Wong
Title:    Chief Financial Officer

Dated: April 27, 2023

EX-99.1 2 eksoq12023pr.htm EX-99.1 Document
image_2.jpg    

Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues
Highest Quarterly Revenues in Company History
SAN RAFAEL, Calif., April 27, 2023 -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2023.

Recent Highlights and Accomplishments

Achieved record revenues of $4.1 million in the first quarter of 2023, up 61% from the first quarter of 2022
Delivered products across continuum of care following the addition of the Indego® product line
Booked a total of 23 EksoHealth devices in the first quarter of 2023
Cash position of $16.3 million at March 31, 2023
“Driven by the continued execution of our commercial strategy, we are proud to have achieved our strongest revenue quarter to-date,” said Scott Davis, Chief Executive Officer of Ekso Bionics. “Record first quarter revenues reflect our team’s success in securing multi-unit orders with large network operators, as well as contributions from our recently acquired Indego product line. Now that we have an expanded product offering across the continuum of care, we look to build upon our positive momentum to drive long-term growth.”

First Quarter 2023 Financial Results

Revenue was $4.1 million for the quarter ended March 31, 2023, an increase of 61% compared to $2.6 million for the same period in 2022. The Company booked a total of 23 EksoHealth devices in the first quarter of 2023.

Gross profit for the quarter ended March 31, 2023 was $2.0 million, an increase of 65% from the same period in 2022, representing a gross margin of approximately 49% in the first quarter of 2023, compared to a gross margin of 47% for the same period in 2022. The overall increase in gross margin was primarily due to an increase in EksoHealth device sales and lower device costs.

Sales and marketing expenses for the quarter ended March 31, 2023 were $2.1 million, compared to $1.6 million for the same period in 2022. The increase was primarily due to higher compensation costs associated with the acquisition of the Human Motion Control (“HMC”) business unit and an increase in marketing activities.

Research and development expenses for the quarter ended March 31, 2023 were $1.2 million, compared to $0.9 million for the same period in 2022. The increase was primarily due to higher costs associated with the acquisition of HMC.

General and administrative expenses for the quarter ended March 31, 2023 were $3.2 million, compared to $2.9 million for the same period in 2022. The increase was primarily due to HMC related audit and integration costs partially offset by lower severance costs.

Net loss applicable to common stockholders for the quarter ended March 31, 2023 was $4.4 million, or $0.33 per basic and diluted share, compared to net loss of $4.6 million, or $0.36 per basic and diluted share, for the same period in 2022.

Cash on hand at March 31, 2023 was $16.3 million, compared to $20.5 million at December 31, 2022.

1


image_2.jpg    

Conference Call

Management will host a conference call today beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the Company’s financial results and recent business developments.

A live webcast of the event will be available in the “Investors” section of the Company’s website at www.eksobionics.com, or by clicking here. Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 for international callers. The webcast will also be available on the Company’s website for one month following the completion of the call.

About Ekso Bionics®

Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. Ekso Bionics is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, statements regarding the plans, objectives and expectations of management with respect to the Company’s industry, growth and strategy, the expected benefits of the acquisition of HMC, potential technological and operational improvements, the Company’s growth prospects and the assumptions underlying or relating to the foregoing. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, information or new changes in facts or circumstances that may occur prior to the filing of the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2023 that are required to be included in such report, the Company's inability to obtain adequate financing to fund and grow the Company's operations and necessary to develop or enhance the Company’s technology, the significant length of time and resources associated with the development of the Company's products, the Company's failure to achieve broad market acceptance of the Company's products, the failure of the Company’s sales and marketing efforts or of partners to market the Company’s products effectively, adverse results in future clinical studies of the Company's medical device products, the failure of the Company to obtain or maintain patent protection for the Company's technology, the failure of the Company to obtain or maintain regulatory approval to market the Company's medical devices, lack of product diversification, existing or increased competition, disruptions in the Company’s supply chain, the Company’s ability to successfully integrate the HMC business and its personnel, and the Company's failure to implement the Company's business plans or strategies. These and other factors are identified and described in more detail in the Company's filings with the SEC. To learn more about Ekso Bionics please visit the Company’s website at www.eksobionics.com or refer to the Company’s Twitter page at @EksoBionics. Any forward-looking
2


image_2.jpg    

statements made in this press release speak only as of the date of this press release. The Company does not undertake to update these forward-looking statements, except as required by law.

Contact:
David Carey
212-867-1768
investors@eksobionics.com




3


image_2.jpg    

Ekso Bionics Holdings, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
March 31,December 31,
20232022
Assets(Unaudited)
Current assets:
Cash$16,277 $40,406 
Accounts receivable, net 4,827 4,662 
Inventories5,662 2,242 
Prepaid expenses and other current assets831 485 
Total current assets27,597 47,795 
Property and equipment, net2,454 991 
Right-of-use assets1,228 216 
Intangible assets, net5,136 — 
Goodwill431 — 
Other assets258 164 
Total assets$37,104 $49,166 
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable$3,042 $3,107 
Accrued liabilities2,227 2,299 
Deferred revenues, current1,296 1,220 
Note payable, current2,623 — 
Lease liabilities, current349 229 
Total current liabilities9,537 6,855 
Deferred revenue1,367 1,475 
Notes payable, net3,534 1,993 
Lease liabilities999 — 
Warrant liabilities259 1,550 
Other non-current liabilities125 74 
Total liabilities15,821 11,947 
Stockholders' equity:
Common stock13 13 
Additional paid-in capital249,237 246,090 
Accumulated other comprehensive gain (loss)369 (17)
Accumulated deficit(228,336)(208,867)
Total stockholders' equity21,283 37,219 
Total liabilities and stockholders' equity$37,104 $49,166 
4


image_2.jpg    

Ekso Bionics Holdings, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended
March 31,
20222021
Revenue$4,122 $2,567 
Cost of revenue2,122 1,358 
Gross profit2,000 1,209 
Operating expenses:
Sales and marketing2,088 1,629 
Research and development1,154 921 
General and administrative3,206 2,896 
Total operating expenses6,448 5,446 
Loss from operations(4,448)(4,237)
Other (expense) income, net:
Interest expense(127)(27)
Loss on revaluation of warrant liabilities(26)(100)
Unrealized gain (loss) on foreign exchange217 (254)
Other expense, net(5)(2)
Total other income (expense), net59 (383)
Net loss$(4,389)$(4,620)
Net loss per share, basic and diluted$(0.33)$(0.36)
Weighted average number of shares of common stock outstanding, basic and diluted13,296 12,728 
5

EX-101.SCH 3 ekso-20230427.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ekso-20230427_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Tax Identification Number Entity Tax Identification Number Entity Central Index Key Entity Central Index Key Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover [Abstract] Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 5 ekso-20230427_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 image_2.jpg begin 644 image_2.jpg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htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information Document
Apr. 27, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Apr. 27, 2023
Entity Registrant Name Ekso Bionics Holdings, Inc.
Entity Central Index Key 0001549084
Amendment Flag false
Entity Incorporation, State or Country Code NV
Entity File Number 001-37854
Entity Tax Identification Number 99-0367049
Entity Address, Address Line One 101 Glacier Point, Suite A
Entity Address, City or Town San Rafael
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94901
City Area Code 510
Local Phone Number 984-1761
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol EKSO
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

XML 8 ekso-20230427_htm.xml IDEA: XBRL DOCUMENT 0001549084 2023-04-27 2023-04-27 0001549084 false 8-K 2023-04-27 Ekso Bionics Holdings, Inc. NV 001-37854 99-0367049 101 Glacier Point, Suite A San Rafael CA 94901 510 984-1761 false false false false Common Stock, $0.001 par value per share EKSO NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Document and Entity Information Document Sheet http://www.eksobionics.com/role/DocumentandEntityInformationDocument Document and Entity Information Document Cover 1 false false All Reports Book All Reports ekso-20230427.htm ekso-20230427.xsd ekso-20230427_lab.xml ekso-20230427_pre.xml eksoq12023pr.htm http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ekso-20230427.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "ekso-20230427.htm" ] }, "labelLink": { "local": [ "ekso-20230427_lab.xml" ] }, "presentationLink": { "local": [ "ekso-20230427_pre.xml" ] }, "schema": { "local": [ "ekso-20230427.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ekso", "nsuri": "http://www.eksobionics.com/20230427", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ekso-20230427.htm", "contextRef": "i6cf32e3966b74b6d96d62f7c37b9304a_D20230427-20230427", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Document and Entity Information Document", "menuCat": "Cover", "order": "1", "role": "http://www.eksobionics.com/role/DocumentandEntityInformationDocument", "shortName": "Document and Entity Information Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ekso-20230427.htm", "contextRef": "i6cf32e3966b74b6d96d62f7c37b9304a_D20230427-20230427", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.eksobionics.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001549084-23-000018-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001549084-23-000018-xbrl.zip M4$L#!!0 ( !F!FU;XD;^S\10 %.( 1 96MS;RTR,#(S,#0R-RYH M=&WM/6MSVDBVW_=7]&7NW76JW*#66R3QEL<0#S-!)#:.%[ZX6NJ6$182(PD; M_.OOZ9:P>9@89^+7CI.J!*G?I\^[3Q]]^/=T%*%+GF9A$G^LD*I20?_>^_ _ M&/_GUZ//J)'XDQ&/$F"%VP3KOD,Q#9B*35WA/E4MBZOF[GE=81[5+*)B MA^L&UFWB8\=3*394$ZK;'N6.M\OJEJ,R5=$LT_>9#L-1X@2:KP>:;A)F:+X8 M=I##ZF"%<58/IQ\K@SP?UVNUJZNKZM1+HVJ2GM=4A6BU,(["F(LE5\KJTRQ< MJG^EE;454OM/^_.Q/^ CBL,XRVGL\YM6T&NX:1Q%C+-2'X:]N&LP,2 RLVULB\GS4@+ --%'LT*X!6CVA\_K'"8WQR M7($-YI3M?1CQG"+1'O,_)^'EQ\I!$N> MK@[&T,SOWCZ6,GY-*])>-7V_O&/ M?WS(PSSB>_PB2[! 6$57K0^UXN6'6M&UE[#9W@<67J(LGT7\8X6%V3BBLWJ< MQ!PF$$[KHB)/BY\A8SR6/Z'!C)33]0%.YYIBF9^F>R1R3 MF6I@^9KE.3 #>M:83^5F3A44TY$8FH?U9@SSFQW 9UT@N/ZM'ESVM/6'#YF7_T!EVAK[1'GV=M1MMS1VYPW[CZU5[Z [:W6C4 M5MM*?]A6W.&G"[?K#C]K;M2[3K1.]_>+]G#_VKWN#WOJ5Z7=:%WWNDVC/W2' M[F'OVFWTIOW&R76/V-IGM3_KG?HFO-,[C7[4;C35]K"IN8??HEXW&D#[:^C[ MHMWH#WK7;:,WW+]DAY]"[_#$=$6]X6#HCGX/^XUOHF_#;40C][JEM$_;U^U1 MF[C#HXO^T"_;?(.QC+C?3=1VUU<[AVVU-_K]PCT5Z[A0.J>P\N'7*8PSZUV? MJ.[AT<@E]NQSMYFWCY7IY^[)K-/]JIPI.G,46Z%8Y=S#>F#8V+94 PIC[O$^L%PFV.ZGB)Z_[>U]>WN]MK>&;9K$\#6L M<5L1$L3 MFGHV+%M1Z<>H[IA5O8"&F5\;5MKRV2<\H"G'%AV=@?W$9RIGDE1 M !N/)+^NY\!S/E:R<#2.!,N2[P:IP(LE1E.=9@RZJ"WW48Q_.V@YARR9I/)) M"IAZB6P%9OP(LLT[XI*;S)]")IZ#D*=(3HC?R=D/6G\LT\5JX[WYJ^7>QP#? MA,V?0 ZF>0-TBCTQ*:SH6/#>U;*;:;(-5>@/&V@+;K@%S M+SB\!.=]:L49J2RV*:7"*(SQ@ O5IZZK5,WKQ :(R\>K8H$6]".WIUPP ML70 R8G;ZC8;Z+B[WVT>+R/(RYJM*C;WN'EP.CUL=]QF7H-^W!%T _)1F \"5/(EW4:-Z4 6C!5C:2X:\G/:GSE$; M/:+V,;?Y"MWY.96/Z8WRL6*!+?=/;;[U%?C2Z]8:+T&RVM=]J>]KH^* ]MI7?]==8;0A_JITB, MZS9.8)Z@4D3VU!U>3,\T@%-@Z3[FNN5CW0M,,#]U#QN4*ISXJN)Y( )L_,>J MZH VHD[)@/-D7"? E^9<"D<\@%U5[(57:;'3\MV6&*=J)%!_#./4K6@=*/VH MZ7;14?-+YZB[U2I?T.R_3-)L0N,0)&\D7J9,U"4ZN@ MPA, W4_S.H,W> 1C#D0SS.@,SSA-,8__?IQ'.S,I_+7!&C6Y!2:I;VK8HQK' MOF$XQ+%,G9EZ96]_G(814JU=Z63;G@F]%(P36""HZHB/DS1'.ZQ\AGV/@/IR MQ"^%QS&5Q9R]6UO0"Z&O[:3UH[N"COAYF D76^Y"R=^/;/0SU3$=7U%L3#W+ MPF"SJ=A6B8=50@S3 )!ZE%;VFF!\HU^!^8=^AGY+(B%MLUW4BOWJ2Z:AN[%J MISFE()L$+@C226]P -$,96/N"T.DZ):U([M*JVB2\G]8" M=9RJ;6@_8H!J6I68VQF@#^F6D*JI6:^E6\T!()@/L<(WF=QSDUH=3]$*:@C] M=74GBTVLW(-?2QJP6E6--16X?/GX%*?<1W'*(^M)!1\'1I2D(/+D(3H[2-BRUB3.7(2/+.?C-+D4_;Q2=:GP$G<:%VH'^'V[T8\ZC:;J-MJ& M._ITT>E>J.[I5U&F0W^DW^VM>HGU3K=G]*Z;5^[H1&]W>TK[^D+MG7XUX#WI M-T39.?N_LK7F+%(E2U TPH(2 W/ -3G8'B13VF>8IOFKY5V7/Y M)65TW4V\Y, K2>R&>LQMJ*? YXWT\\18_C3:RJXV!%,RU%N&&_@[MO&LOW[6Q)'3M2B4!)BI)\P%,TG*1AQL+" 09&0[BH M<,AJZ3F-PVOY_.YG"+B?!&Q2E5;1BH>T>/EB@'V0C$9A)J*HD)!QJ. 4]X'Q MAW$V3\;_?0C;JAY5CZNH.1I'R0PP=IGW(C>IW@7/NP\1M;5#Q'6473HD?$#5 M-_;S$H3S/F,IS[+RO\\P ?(FF.\3S-=K5A#5"?%\Q<*+\;<7*!@.SQ%WA_?B2 M L[<8^<1 MV:;0O/=33E\MH_PKX1GGVAGUN:YRQK%IV";6N:: @6DR3(E!+#,@U >X[!E$ M665S[QXSRO5S G3Y99#$K_DXZB_MC'X6$-W6="? EF)Q,/UMBJFJ@E7C40^, M&DZY;H,(LG4,&[4FA9XS2N9>QD0$8[H-C?I7AG(>\;'8;Q3+#=\5#O!H(M@J MHD">@%V,;US2$E,VJN:ZK"M?_F XZ%_N_PDYIHSB"]P7)/H\B'HPX/X%R@< "TR$L&?A:!+E-.;) M)(MF* -4R8*9;%DV2#S833H_YA,%"_&!$J<0C6?SLB")8'#13O@Y0G&"E:&= MC'-TR&.>@H+IH;N8]VVJ44\ MAUH>V,K__,6Q=/W])FMY2]PY!;23L<$_22H]!\J6> 6XNHA8:+QP$^9H$G&D MJT;)$/+E&S#BXLL.L=#!IR,$:%N%B@^)'GX@1;]QC*TYQG$"&A?L47S>!N$! M$B1Z8Q;2FOB%T\NNIUBU1H M5&+5.J\@.L5$76 72[?D;IB%KE2+FN_6]?(W:G\@M7])N= -1"8(>2-7*(%I M)PB$N^*-ZI>\&<899YZG.8:&#=\T@>HYPYZXP4LTS>)<52SNJV]4OW O-N78 M7\"N>[4%HC.L[GCOMN,!1=TW+O#3N4 KRR8\?>,%FS4 ]4Q>"&2Z@2U.P&#P M] !3WQ9W^!5ND4"W'>V'>,%=1/GWY 4:@'7'WXX7E'4?R@N>AY 7K*#";<)3 MSI8 <)-$0#+#THT"BZ[?FP#BI5VPM!3K!R]8&HK^TZ\LJLJCW-O4M:JB_92; MD.66%.?=:ZF'RM(R_<6&O$0O_AJ8/-'MBA2(Q9U\?X#\B&;9%G>'_C[@2:D\ M-CJ>C;PDVED(&/B+P"FC)OZ;8>>65]8E9O&YR !N>C4(X? M1JYZHKN-;V'GM'_15EM70A5=B[7W/>;8OF-C-? 4,%$IQ8[F.5@Q%>B M@)\MI^\*%KPACY<56/-48F9N319)C58='$)Q>/4A^4]'8,LA^9^UHXC_=C3K MG[*Q!R('YFMTNC#/813VAK\/W88/_9WK;;4_Z)R>7/=/OU[W1SVE?]@/W/TS MRPJX9I@B"0$WL&Y8!'N!3K >* 933$LG(J#?I1FC?Z[%C!W0<9C3"+5I>L'S MK>-%G\<5T(J9\(!PY,V0+X,WP,R^ $V5RPO5*Y$5889@BAP6>BZ,@_,TNGL#.*X,Q3.# MK'M&P3C45.\P#R!+-M#S%]HA"?I;K M]Y'C&%^@=[05?(?)B9#:.SEFN!:&-@!^R"/NBV_*Q(ETJTXR+FL!V93!;N*[ M(:%TM19IW06RR[&BF1AORN5O6 C&):4 M4C^O9Y,1[.#LF0[5-L-\)=?^."D0I9[RB(J[/&O9]V_U?ZGX*[=-J =Z^B1? M;W)?PO[BW\%-YHDQ/>?82SF]P#0 05JGT16=997:(WPIX'F"OELY'R&UJJCH MB&>3*)?_N)NFM3-MYR\?2$MJ"_XG6^2#E M',F\R3-)4G!.627Q%UIMYV+) M AFS/$\O!-V NLQ![06IY-9JHK MD-J @=X0QBD0C*,HI%X8%4- CQ(_LV(>N\5BQ)M%>"RM;@GY%K%.A-(G4FDH M@^4WG%\G=X;$EG;9XMIV;\S!$66@]W"8D;R_($6 [$0FN!84D 2[0@<"+20J M;Z&*B9R78?;+^;C$AX8F(%#$[LJU%O-=IYH7J"1NTF2?15PY584L""69\D&$ M.,Q15Q).]BK NL/>"=M=>;_^[SWK>.JI%I.Z8S)/'.*@5PWGASYB!")4(9OC M#7XX*W/5UHV?WJOI0+?;Q6,\4NJRYW!"ERC_@*2F&_.]O4X -'CFI^%X2 M_K!\_9#BH2<4B^D,-D(@"!X- M^[+_F!WFG.\@)GWC_[!-'M%P'_)$)C'Z?5 M03X2&5"KY$.-/CSMS1;(_;;S+WGGOTCC[*@TSIA475>_]7(G7CQ>.LJWO?VA MO?UEJX]($D5_+$)_V_*7N>4'R:7(GRG,NI8XOH>5B+Q##9K3(FOP#A]YG+'R M0^M@^@G[L26U8"0_R,[*;VJ]^QXOV'!\^EUCYA[?RIN_]6$.J&?-S7'<.G3W MNR='S:NDBTVB&?+I1)Q.29=? MX><5PWA@#[H)!\D*2R.;?() MO9!=?GC^&]6^^?IE&(L'N^BEGNP MV8/]O$Y6\Q(V M@__ CHWV_A]02P,$% @ &8&;5M*N _2 @ V < !$ !E:W-O+3(P M,C,P-#(W+GAS9,U56V_:,!1^YU=X>9YS@P*)"I76KM(DMDE=J_9MS33((O:Q(>UA>XISS?>=^G/.+;56B1Y"*"3[S(C_T$' J.'3S<+="5H4P'7Z%("T9"C#=,K=)^#6J-"B@K="[EFCP3C MN2-=BOI)LN5*HSB,A\=:F4[#\&RX_$H!$KBR03B\<=E M&N89&4ZB&"&'@55G1$$'A[42/;@5 M9*:.C"J?BBJP&8>C>.(AHK5D6:/A6LCJ"@K2E'KF-?Q70TI6,,A-U4NP=>T! M#M2:R"7H;Z0"51,*[_,['R!D*\*J6DB-^(OLMB11DB3!UN;HH5T%%X(2[<;B MU9(X/+9';'HSC/RMRKW@76[[AAA7FG *I_@V7[CC_8L8]OT]+8:.=WH,SI@" MZB_%8Y #LYV+7W:O7H/; [:'OD_"N=".;R6MK*X9+\1.8$0V\+2+_@:*;F6> M[<$+(^)>*9%4BO(O\Q344M0@-0-UN$/.P$I",?/L .-N:G^6)/--)!WDF8-^ M"ZPZ,!0H%_M,.JY^J@U7F0:4L*O-_YQX+>'4Q U%F5O#-?K$_"W_UN@1RV=> M=ZT3GG_FFNFG+V909.7L=CH/6%T >50,,[ M_V\.CL8JVIE%!W;_Z,^#8W-'CAH%^7<^=^?C K;D%O(&D9*2-N7IO'U8K]): M8=>@=H&#_@;OO@^VW EV5\=\\!M02P,$% @ &8&;5O9O:^]G"@ 25X M !4 !E:W-O+3(P,C,P-#(W7VQA8BYX;6S5G&MOVS@6AK_W5VBS7W:!LB8I MZE:T&70S[:#83%LT*3K8Q<+@-1'&E@)9:9)_OY1L)Y9-V2(5JQH4:-V$/GS/ M:SV'1Y2L-[_#UDLTCQ[>X)>P1-/9CP7:7;U]N3;Y0<0G_QR^N+%F[\! M\,>_OIY[O^;\=BZSTCLK)"VE\.[2\MK[+N3B3T\5^=S[GA=_IC\H *?UF\[R MFX%;-7>7$UP1#ZD_7HD]7P^YWQ=WX]&B5),JE_^SATD9H&ZK!H\L?O MYQ?\6LXI2+-%23->3;!(7R_J'Y[GG):UYP=U>:TCJO^!]3!0_0AHBWSTZGXA M3DY?>-[2CB*?R:]2>=6_W[Y^;)TRF50C)IF\JC[9+[)(+-+YS4RN?W9=2&4..RN*1M1*95*I1&&E\N]MDTUZR'\FO>6NUF<0 M5Z?[Z;DT[O/TT[/)O=3U01Y?\,8TO24O#ZCWF1CJV'V8EK/LRK=&U+E?2DS(9?5LA':2\7;$_UJ*F0Z M?9^5:?EP2>\_"KWVI2I=%N]/MW,FBVE$DA"I6(% ^7IQBGR]3-%$@##VH<(^ MX5S%T_+QX)[*#'R[6.NH)^LXTXE%KF4+LX5DN];R9/*?8Q>#:<;;.1.I;SAJ99U3[D MQ;8;.>_NQA.7"YU(;<5"\E=7^8^)CJ$MP;AZ :H7-8Z'(T]V/N1WQ5HW+?@! M_U/$RPLA"]T/&U(R'+=G.F9!9Q]U M);G_MWR8"AX'D<(1P 1)0!(%04*H;EG#A/EA& A&L%U!V)IAI(5@I=*K97I: MIVT!V#:R*_@][!D&^.[..(#>DGT/P+RH)$GZ$*!*BDL>Y3!((^AYKEQ YFPRPC!7HE\>7ZA5>)]3YG MTA9LD[%=X>YIUS" VSOE /H>)WK ;HHZ,/![$MN%?M]@>_ O"UIM=ET\S%D^ MFX8T4"),)(BX#"K8.8BABG0K#_T01CQ1$G:%O1%Y;("OQ'E+==UQ;MIU&&%G M$XZ,;JL5HQ+H>)Z\85S71=3-CF'6SBY..*R6NRGW M6"0W@@V\-NZFL;LD&L;80_FED&?Y?"ZUKNH*S\?%XE86E]7V6/%9*7VL4<&9 MI-7)+&,<$!E2D$0L 0+%E"(,!4:=3VL/338V:+5>P#<$>TO%WE*R5VONCO%! MJP]C_9P&'AGS7MY9@=_5%*="<##X8(6A:YJ;A:+S>^P+QT4^2WE:ZL;@=ZI9 M3.EL2GV,0\0#H!C1I8)1 2@,,>"QT&?-4.$@%EU+Q6[XL16')X7>6F+W6F!P M[S#]_3PY,N\V=ECAW9ZU$]"&<(,AW)[*)K1[1O7V-@RUW-AR MLVG@;:U.#KEO:>UZT']#:R/FS]G.VDVJ=3/+,-05\(\9SXN;O*@O<%V4NFZ< MY;=963R]>:\&QN#E,?>AGI4"XZV=.C=.R//W 9Z93L;DGI]C;[ M\E+=LCC[+=!ZTV['N,/%H(\=1R;?P@DKP-M2=J)Y)]A@Z+:EL3?V7?%'2 MV7_2FWK)"7B(610+P#"*-9X2 8J0 I!S1E3"_(BX7;AN3#,V4+<;UZ583ZMU M6M6-SEHV^,Y^#=SC=[7*O_^]%6I8RJW;V M;K/536V+*:.0*8(P"!0A@*!8 A8'"0AB*4D(N<*,="7?.,/8H%^)])HJN[-N MMO$PYKW-.3+AEKY8@;TW=R>FS1$'PWEO0ILD[Q]H#W%U\O^ND+1>6^*J=\;Z M!%VH4+,;D0@D, H!"U1 .(D.I$F>Y+#?,.DRHJP5'!K-C M]E9 FE)UXK 1:##\3/(WJ3/^W@&V_(3F4D0P0#!D*E_R(ABP!+ M$A\0WT=!H"(HE>Q,VV;DT>%6B?/^NY;W/PO@&H9U(,[5AF,CU]4!.^A,V;I1 MUX@T'':F!!K<&0')E%6SOLKA*WY.UV MC7@[V'!7B%O2:%P?;AMCC^?ZB_V7^JU30F-$ ^0#& D)B-++8B*D C$,L. L MB$+,NJ*Y&7AL6#X^S: 2UQW&AE>'071UX,@0=DO>"CU3ID[8-0(-AIQ)_B9N MQM_;H_9.QQ!5G \S>C4- D@$C16@C.G&4U2L)8P"W9K20(1"2DR[LM:(/#;8 M'L5YE;KNM#7M.HR;LPE'YJUC_E; &7-U(JX9:3#DC EL,F<>X-Y^OK_GU_I3 MD9_T)S6- HY]/X @3@@")( A2%"@F]$D#&.!0QS[R+8%W9Q@; BN-7IKD5ZE MTKX+;9C8O1-UM>;(8%JZXM2,FE+OU9 V @[>E)K2,36FQG&N5SF_RJNT.@W- MROJXB\.8L%@0P%BD%T[F4T"QA'KU%%0P'F"JN-WUS>8$8X-W=;GN2:0EO$83 M#\/;UYHCPVOIBL.U2W/J/:Y:;@4<^'JE.9W=*Y4MXUSA?3^7Q56:7?U6Y'?E M]5D^OZ'9PY1Q'C'%$J 8TPLP] 5(%)8 *2%YH%?G,.[\?=L]\XP4Y;56;RG6 M6ZFU1=IL;5>R>QLV#."V7CF OM>)'KR;XPZ,_=[D=NG?/[SG?4KU38F?BR]% M_B/5\J=^(!(,(PH8KK[]*[D"#,48("9#F@@,5=SY%'C?1",M X\WX#S>/KL6 M['BWTK:_74M!?]>&J04.AKG?L]3B1O^[EK8#_YS[EEK2:[USJ6V\^X[SX_,3 M?]61IQAS22$3@".H:T$4A2 .(@8H2;B4R">1#&VWGALSC*T(/&[#+E5Z6J97 MZ;3?CFX:V7U?VMF>H3:HNSKCM%=MS+[7IG4SXN"[U\:$3-O8YH&]'QRP^3UV M)?PH%+JU#Q6#@&"I0<:4 "5"":G^$W#?\9$!?Z6'!3S+4P)Z/1_@+_)D@*,_ M$N!(#P,8PV, [!X 8//5_\U/XER_.GVQ_DFZ?/;XZ8O_ U!+ P04 " 9 M@9M61-,*R[L& _,0 %0 &5K?^G2W]>ZGV\UZ]@WJIJC*PSG;I_,9E+%*1;DZG/]V\8'8 M^4]'>WOO_D+([W__=#;[N8K7&RC;V4D-OH4TNRG:R]F7!,W76:ZKS>Q+57\M MOGE"COJ;3JJKN[I87;8S3KGX\6I]8"E5.M!,*%A&9'2>^)PXT9)"]-P8X/IO MJP.:@A>&<>) *B(MB\0%[HGB&L5M\.!"O^BZ*+\>=(?@&YBA<6_=4_1)OB.4%*($2"[=\V M:7ZT-YO=PU%7:_@$>=9]_O;I])%*^-I4 >TH8K,?J\VBDUEL@^S+]+YLB_;N MM,Q5O>D-WEY#9_K%V[LK.)PWQ>9J#=MSES7DPWFW-.FB3B4WG4E_';3NXD_# MKVIH.O'N^AF>>%B^L_%_X038=4XUZ%4?YP;B M_JKZML"%,=Z<=U\Z0'D/YA-U]\B]SNXM(!R)EDG0:31E#@1+;$@ M1:G"*+._U_;8ZN\C?ES'654GJ#$O;=7Y.CZ)_N-GXD%B<>5K7(C$RV*= MMG=W"6H7L6JK'2!W'Q8T=SY#KS/4-:2S^ZB\Z%SO68O9&GK)743\'.JBPB>T#J*"F"X5 M1B,Y"2:<(%:U7Y_B;GC[3[A;8N7#LDB1I"0U5FF&$JMM)L&(*+U,GHIQ.\*S M:@=Q04Z="V.P?&,R'&-22UUB^[#VJZ7U%+Q5C%"!-LN<-''2.L*\-"Q*3C-3 MHTCP2-V@X*OI!O_UV$TB YQB$UA?576/^&<$'DZJ:R3RW4F58*D]2SI2111 ME]!$PG8L)V*]5RRG8).B.\@'_]&(0031TR7(KG&>!&T^%&OX]7H3H%X&[-UI M%(X(E1 7B7V[3PR(9F!SHAK;^;0#CORI<1 AS-0)\4H$)Q']"W][FA"K(A?W MTXT'1[CD65D5B;$)*V$O<;?3CA(!+"FIK-A,BOZ? ML.*5@$Z)$WUA]+$^KZMO11EAJ8R6)EM/DM.&2(,>.1F 1.,M%D76,J=W1XP? MM ]CQX1'ECN#=DH4.:^:UJ__55S=%\[!!I8"Q7+91.RW (CW"0CW6799D0N0 MNR/((]W#Z#'A:>:.8'UCZ&4 M@%%T^%[;, ),>(;Y:NC>..3=?ZKK\\NJ_*.!XEP8BOVR!XJUL3:6..HT<5H% M*K-6@H[;)G[4."ST$QY9CH+PC7X\%\8S9\KM9%+-JB7/V"!4Y=^/52 M:AZ3])YXU0]AO29!@2" >8Q&+IQUX\803W4.X\&$IY0C87QC$IS7T#$8L+#M M_Z/O7N^H/V:T8TF5,V",(TPJAUXHBOXX3L Z&IWQV>EQX\F7=0\CQ80GE3N" M=5KD.&V::ZB_]T5R1$-(3E+FJ9N@6!)21+2<9SD[U4WA=TF1)Q8,(\J$1Y<[ MA?BM-Q2(U[@IWC$>+HIV#44@E" MJCPJ]H_4#7L_:L+SR->#-Y&'_OUMO/3E"OK7>;*U,?FD"!-*8T\D' DR&6(2 M4PZ,B#&,FR8\IW48!R8\=1P-Y22FC>\W4*^0RO^HJYOV$C>W*U_>+;U,V <) M17@2Z 8H0QPP39B5QFFD=4Z[>#_J6>7#B#'Y>>-X8'?&CW>+)U">X8FCO8<+ MW:%[X_YH[]]02P,$% @ &8&;5FBA ?4-&P 18 ! ! !E:W-O<3$R M,#(S<'(N:'1M[5UI<]NVUO[^_@I<=TMF*)FD5B_UC.ND3>8V:6_L3N?]U(%( M2$)-$BI!6M']]?<<@)2HS99DV:(DY(-C2R0(G/4Y"\#+?[W[[>;N_W]_3_I) M&)#?__CIUX\WY*1R>OIG[>;T]-W=._+A[M.OI%ZU'7(7TTCRA(N(!J>G[S^? MD)-^D@S.3T^'PV%U6*N*N'=Z]^44AZJ?!D)(5O43_^3J$C^!GXSZ5_]W^:]* MA;P37AJR*"%>S&C"?))*'O7(GSZ3]Z12R:ZZ$8-1S'O]A+BV6R-_BOB>/U#] M?<*3@%WEXUR>ZK\O3]5#+CO"'UU=^OR!7/.P1&B3PD)#VV%]N]>]![X3(V)O]1(^9C=>H#[Y>A#3NP2,Z(DE$ M>([#/[ XX1X-*C3@O>@\85^3[.OLR7@?/+DK@'39B)X(1'S^C:W^7> WE2X- M>3 Z_^$&ANG$_ =+ N,JDL6\JR^0_+_LW''@B>K/H9Y4'>X/>,3R13LN+O/[ M;YRF?3'_\_(4[UU -C5KO0#%O&R^P)3X:OJF>8IKBB1B<-Z$R15&\H#)+%Y] MZ7<\9))\9D/R180T6I4$K5D2. T@P?M[*3!ZT_F.?(Q0 M@B4C/"(_\U@FY#\IC6&J6F2_L <6I4PN)=;N5JQ&/.<)/,U[7 P4#3[ [VRR MO& T7ALN_4:$ QJ-R _V9?+G^^?K]KQ9!%>E6+7(]B'E MW):E^);/_V5GMYC08-[(E,!]$($/QE%:*&Q5\N8SE3[]Y_MO&NT+\O[?M[^] M)6^2/B/??]-V7?LBXX3ZR[D@(LZ_*(Z9??O6(C0"]OFI3.(1"]9P!(1D81Y_0C6WAN1+HP6,A\M%-SHYW=R^#.5S"*)\.F(Q&P@8K3I71[1 MR,-O8R;3()%J )QKTH\9(R'0HB\)BWRX^!.-O3ZI.9H!U56LR]_P<-X=+;>)O1+)YL7N-.]BBDA.O>HTD 377I^#H?-! MACT1XW^9U1-=\BU<1& B 6@5J@V*=E\<"#K *&#B(A9]ZJ'!>+*0D'@S(HS0-D?P>C8$I(@C$$($HL@B'0["+ M7^/?'X&T/?$B"VRIR:ZP1*'Q]WG, IK NB[0DU9JU?8"]-@!6((C* C7JN^0 M->#4,N(3_,J(^?;%_"!3-A#S"+7MBW!$"_M[((D,PL6!TP3*D/H@MZ=,'^"1WMW@;7"NB'D8= MF=<=2VPB*CX,8^4P5U+NDUL/0F7RCCYPP,HW,$Z7O-(6!=7DDC M#M?'@*@E&7)0P0!B'T8BE@Q%?$_$@ $A1 Q3I7 !"P+\'VD8\XXBGM1H 1\9 M*] (,1?U_DDY.C/MC*;,:I5\%D/@!,@4D%93$Z$\A /^Q/T! ;I,33-S@P76 M35RAXDX -@49TTEYX ."07["9+0T/R!^1[ *-\$U/HH"W $* (0+22\6PZ1? MS?ASD&@>%6%!R/_S..KYHJ.> UC\8BN0)0#($ 1W"@KG85ZN1HLBO"STS+(G M('8(CS$(HBC>(%'?NM7FW(B2AF Q8+H"HT\%FJOD#K[($Q"=+?C!^>!SK]CR MBU)K4/'( . M8#Y?>0@V&ZQ8_>R[)\*EHB#,CU9O??>T1 B PQ2L*B]DZ*8&PE4/8IA3##P@ M/@ARLBZZ?VZ"56-C(/8NL7F10'.: O0-F,Y10&@$+,H^]H1,Y)XKRNUX:2 # M]TR)+KA+%DDF5U0<""Q1 014%S487AX I 1;@1X+EF",96VMY*A'XL.Q.1^AJ4%Z(,!$ 3!BIE61R[U:GW"2;@+U*Q60V:1#I7[5/8"&--7.C>;J]#4+^8S9A7)KC:*J8YW$,:&':!E M-@+09YY SXR.\@)[NXHIT?F$Z6P%/[\OJ\+;DUMH1PID]-);GE&LW4IEWEE= MN(H_^_$DK]=CE0Z8K_L*[<+\SVDPI",YO4K3!?':71"ER6X 2NR"KT3G T0, M#C:1\8E&(*,*[PW!6I$^>%H(.[W)\CV,)'5YN\- 7".%?A/BJ#)\S2:#:E@E MO]^1[[^IMRY(?>KC]W M A:=(;N>"+.[W1=<,O;(,0BO.UGB&3SE+J-^A6X 9>Z2)!Y P'O4)(ADV"Z) M425CH5+@'+00 1[(70!!!E/:#BJV6ZU*W6Y5 M:C: 1\2'OH#9@E-3]R"Z%9@M=BJU5KM2/W/.U$7JR1'5#9;YE3K*R!5%Z08- M\&E%!1'1HY*/@XLH:[B9J7*KOA-6U!]\\&'VWRC+TQ%I,E4">JV*_J+Y;*>B MO\=,6JR/T[UJN%3"P2>J#C44W,P3ZHQQL5E-(795.U-U,(H]5=T1Z:OD V]1P-('!91\=,/PA$U#N7M*W,.!,5>1MZ1PA6.Z )Z.\;K:D M$2X+;-4DJN1GD:JP5<6#=L,JJNFX8"IGBFP\D>.FO$J^9$QQP'2EBI=])H%) ML-J0Y5H;(F;QT@175&%^#V8-,$4\Z 3)D-%868I8 )*6\Z9#Y_2JTYV'7*,5 M$04CC1 55LP$? '/X6'8(F3A:KF;U =-C\4K S M/$LF:([@M;,#^G&SD-,IG40X!6VDR RP\7 \%LC*DL5_Y50@%CFX3FK 7:0LMC;V_!C,BQ\M4 MAI'"19F6P[-0J/O"#UL2D"S!;"AX"'8 *T$A>NC5D/1LF1U2 MB@#,[OR-\U7&,2S&GF 48:%X00XW9R%=[A>LK,-"C3GIJ5%1 ME'H"$*_#(M9%9Y*YB/F*@%7PB1/KG7LUW:*BT2@/![%XT.NT%LXLFP]*V4:#O2"E;$,1IG7U9AG@JV!1:PGX(,JN4V]_B,L4YU#R/Z0T4@1"R0$ M_#%VW) >&'GXE.&*DW025%N8G57F5SEU%6TJ).[QV$M#]$#>N" X4L.#7($[ M"$"4D9P>397TL9%Z/L*QS&47"/(#R&\:Q\A0H,7?.C;%9\^*@P4C!IQUX9>B M4,!?(+)8*==3*9)/_0U/EJD:15?'HU3E5(&C,9?W^B+0;!EA" %!PD 0, M[I3ET"J=$4+Q7V1=5RR71!Y1#[A(O5&N/(],!4=0DC$M;CKILW"Y8Q7%T!"P M7*SZR_5=3QJ< H3 ^R,PP5X?@9;J:M&V;TZHQPL7N"XL5&'5(E,['F0L7*37 MQ0T_B)C1!X.]#(EC5_ZS^HZ.#)#'J%!9#UNBHMALK\R2>%*DL;(K"XJTQ5+S-/U_D..&]5E2 M= &[I[&2U:Q=DG1B0?,V!OC08P/%]Z?&S$=:PGJYJ$&B"RS7$@9W8=TRPGP& MS"5[^J*!QJWW<+>V?@%0C_I@6%!K,\E'Z4T3G(\' JGM#5@7P'W9/XTKT7[NDTDX?H2G\LXS3P(7YPI MPF@8-!SL"(\6N_>"]F4]K]T4[5E>R];*@O7N<;Y:!5%8W(89BRAB@37V&@N% MF6,F2JG"]"7C 94+Q85F@$>9]CME^2C0U'+O1@5C,SQH[)3 #$2CORSV(5BXPS%FXR/PTM%HSE696NG)U?S>*E,K-;72+8:P4R&CSY9$KA : MT7N=4*-CKX8[&?3OL]=/]S;[@DD5E:@H*J'WRFJF S^SOO(QE(J> F$!/G>, MP+#+B [WII:XM$J=@,V?SJ.58;J+!07WI_CD!MS3\FWRI9FLZ[B5=K-5<5K- M=OEGRR>58?"+L\YU+2E_B>^.T.W.[RDT;G>?W>[59:*J1F.)Q/UM%5A90 >2 MG>>_7$#( 6!]=,XC-4]UTR9D/&M6W;,F\C"!.25^_N",O57%WM/$G_^N474: MR[^UJ\[2[QX=U:[6ZN[6AZU7G79[ZZ,ZC6J[W7J!R=KN"TRV5FW;C96&/56R MH.4!)$X"./KQQ&F?3&R&VHE[[@Z^$F?1H3IS=74E?2_&#K)*-D7/8ZS;O7ADV7CZR(X6/1>5J$5?2SGK MR1?S\LG5KB /2\?( A7LK81!B (DP9?;RK+8A#3VK1MUQR#E\K-HGJ[43*T=&!EB3MU M// 63,D6O>EJ18H]D6"W937.-DQKK5RMV1><=%"LUMFZYNE5.'L,-:;? M8]S#B,>0X&;R?U*N-@^J[-&NH=!!2;EKU1OUS7QP.QBQIZ=;8A^2V:[ M]A!T?<'?*Z);49OE2X&Y]E" 'APWHVA+ M4@H(M(>2VK"UE1_9"JI[5 MJ'M0ZNWUZ]S'Z7I#V^$3) ML7>X<3UF71V5K("B0&;"X[KZK)8 MOS+E@>'[\ZR\D=^47-;/YX/,F_:/\C/)M0U4*KMA^BP2ED? S[-)Q^Z'FV[- M@*5R,ZF<_20&+LW7%-2;1PKAFX%+STA:U-<-$ Q8>FWOX>Z01<=029K>.UVB MO-!!%>+/K$;-[)\^0,8VK7;#;)\N2>[(0* -DA&UICEPK_1,JK?,$3(OGNV1 MDW3/IKL/CSN+4 .4LV&WZYYBF3UDDF.=G>TP'W<,N&0N26. R?H1T]K%6P-+ M]B)I;(#)6D3^D\8Q+5=F9@]%U6WLL!7$L&@U7-)HK%L6-[AD@PW-D8@JV\KW M'K<#=-P=1N6&1:NPJ&4V.+]"^:A$X.2@J@M.PP*(7<;R@N'L,SGK6&?U4E8$ MCP$(3>_$96HG;BG>\+CF>SC+/T/3;;J:1-Z(,!01/!4$<]DP-1PR MS:7/W1T(4TVXB #1X_MZ*CPB'AUP0/@F.;!^RK%^9KEK-WV9!,&KLZEIV6=F M/T[YC9/GI6$:T(2-WQTFPD',^BR2_(&1'@5S]2804KXU &K]UHVF*9"4G$5O MG-:<9!OT5![^% V4S[KXMD>F7@N!<\,;*[&ITV.FR[!+*K7-)I M@AN?X'^?/UQ=PH]\RMD2&^UJ Z@P$%)5",YC!H$N?V 70^XG_7/'MH$"Q?NR MI=B36V@')IXFRV\I3-MC4<+BU1EY [=U8KXQ UV<2WW,M9P(^OE7EQVD4/&[ MXL]^G$]P0'NLTHD9O:_0+LS_G 9#.I+3JPQYE#^V[51MI.HL0:XN>=@C-$A^ M/.$AC/F76_U[T -EB[W93Z:95!]\O0AIW(-'9/3'X6>XK\BLO\Z>C/>],JVU MFLS_G&/! N%0,GWR!&_4#R74$XE46@0K"^A LO/\EPN?RT% 1^<\4O-4-VU" M1F!@U=9,S!!>]N3LZZKZ:L8D9!QPJLU6:^G7=M7Y[G%7DZ\A$A$KS96/K6'J M.[?J./555[\R45VGVF@W-AKV\>_JSLJL6GVR=K5A'Y8$+(QUG,;)Q%PN14': M_N_(O;<6NO?W]U*0G\"1<4^2#Q#'P-2E13Y&7G7*VQ_6JF]$Y+-(,I_ ;PIX MJ/SV;0+_X;OJ)1%=\MN Q11]O#Q@2KSY&)&D+U(8PP>^LZ\> \ %*R>R3V-& M:"CPT/RWZ)#>_!'1U.= J;>+*#+CMIV&RMHL5JPUJB@OH==//O[LA,1B.!L/ M[!=K[_HQ8^037->7Y#T(O$^0BY]H[/5)S;'("GF*K9C*0Q*,#7Q#:1:W8X*M M'.^57*]GY<&CFO+BY,29L+[1\A4%>^WGEX\-S^^?VH:+R9>7S MS9/[>=E[OCR,S,-(Q]]FO-[%*VW);17FPI@;J- MO5?E(\3+K?5XSETI(P>/%?-D[1%1C["O VRFD*N>-50^?FW;2Q[F&.7CVY:R M/LH!MTJN;[(LY-# MU@V#5F206]O-*?AEU%^#10P6,5CD2+"(?GGWFRP%\Y;PR!,ALTC$$M-.>MAC ME(]OQU3__HAG!#&9Y-G/@U:TXRZHOG'$1#S1(56H&3WP8TCBF,)O"VR<.VEX?>3[ 7>,]829;\^K>U+9+Q)[R*?DQ MH>@_HIC!-/[+_.*;6M&"=T4,%T9XHG*?1CV#KP\7P+F.>1]VR5GTQFW4#<@V M(+N0<\SR'BK5>-#&^U=FUM%&Z:<8^E%^ S2PCF3P[:XC_SL?QHF;+M;2=+'.OHB\ MA&VLSYAB^;A]3-AU\NI4BW2HY)X^"(SC*^)] VS-6X?VQ,W;U=H:H7KY$N=& MW/9-W,K4\U0^*VR.<#%7&E$Q5YJ ] #4K.MLD3V\2#"T3_5'\PG%&9%>XQ$ M:=B!R%1T=7 J\3=/A*&(8&K"NR 5 " <\7 !E:W-O M+3(P,C,P-#(W7VQA8BYX;6Q02P$"% ,4 " 9@9M61-,*R[L& _,0 M%0 @ %I(@ 96MS;RTR,#(S,#0R-U]P&UL4$L! A0# M% @ &8&;5FBA ?4-&P 18 ! ! ( !5RD &5K